TELA Stock Analysis: Buy, Sell, or Hold?
TELA - TELA Bio, Inc. Common Stock
$0.70
0.03 (4.46%)
▲
5d:
-15.65%
30d:
-19.36%
90d:
-38.6%
WAIT
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When TELA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TELA is down 15.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TELA is down 15.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TELA is currently trading at $0.70, which is considered oversold relative to its 30-day fair value range of $0.73 to $0.85.
Technical Outlook: Technically, TELA is in a strong downtrend. Immediate support is located at $0.60, while resistance sits at $0.90. The stock is showing strong short-term momentum, up 4.5% recently.
Market Sentiment: TELA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.70 (+302.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TELA is in a strong downtrend. Immediate support is located at $0.60, while resistance sits at $0.90. The stock is showing strong short-term momentum, up 4.5% recently.
Market Sentiment: TELA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.70 (+302.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.73 -
$0.85
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.5%)
- BULLISH: Trading 302.9% below Wall St target ($2.70)
- WARNING: Recommendation downgraded due to -15.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.73 -
$0.85
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.60
Resistance Level
$0.90
Current Trend
Strong Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.28
Wall Street Target
$2.70
(+302.9%)
Revenue Growth (YoY)
18.2%
Profit Margin
-48.4%
Share & Embed Analysis
Last updated: March 30, 2026 10:27 AM ET
Data refreshes hourly during market hours. Next update: 11:27 AM
Data refreshes hourly during market hours. Next update: 11:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TELA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ew Healthcare Partners F…
BUY
3604000 shares
2025-11-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 48 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 56 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 58 HOLD |
